Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Op-Ed Việt Nam’s COVID-19 crisis response can increase opportunities for the country to emerge as a leader at regional and global levels